Latest Industry Insights

We spoke to Dr. Maximilian Zucker to learn more metabolomic biomarker networks and the role that they could play in the future of diagnostics.

Data underpins every decision in the pharmaceutical value chain – from production line optimization, through to quality control, quality assurance and batch release.

We find out how SOPHiA™, a recently introduced artificial intelligence platform, could help improve the adoption of liquid biopsies in hospitals.

To learn about some of the challenges met in achieving FDA approval, the advantages the test offers, and how its use can benefit non-small cell lung cancer patients, we spoke to Joydeep Goswami, president of Clinical Next Generation Sequencing and Oncology at Thermo Fisher Scientific.

We spoke to Lee Buckler, President and CEO of RepliCel, to learn about the cellular mechanisms responsible for hair loss, and the potential that cell therapy could offer to treat the condition.

Two of the most important conferences in genome biology are coming together this year for a single event at the Earlham Institute in Norwich: Genome Science and Genome 10K.

The SeqStudio Genetic Analyzer is a smart and state-of-the-art system that provides researchers with a truly plug and play system.

To learn about the limitations of 2D cell culture models, the range of 3D tools available, and some of the advantages they can bring to researchers, we spoke to Dr. Richard Eglen, Vice President and General Manager of Corning Life Sciences.

We spoke to Dr. Markus Tolnay and Mark Stevenson, to learn more about the NGS Companion Dx Center of Excellence Program and what it hopes to achieve.

We spoke to Volker Pfahlert, numares AG, to learn about the role of metabolomics in diagnostics and the advantages it can offer over current methods.